Bipartisan legislation that would restrict US business with world-leading Chinese biotech companies and their subsidiaries was approved by a House of Representatives committee on Wednesday.
The House Committee on Oversight and Accountability passed the bill 40-1. To become law, the bill must pass the full House and Senate, then be signed by the president.
Uh-oh! Daily quota reached.
![](https://cdn.thestar.com.my/Themes/img/trial-img.webp)
Follow us on our official WhatsApp channel for breaking news alerts and key updates!